These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2272179

  • 1. Platelet abnormalities in myeloproliferative disorders.
    Holme S, Murphy S.
    Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
    [Abstract] [Full Text] [Related]

  • 2. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
    Emiliani C, Ciferri S, Mencarelli S, Mezzasoma AM, Momi S, Orlacchio A, Gresele P.
    Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
    [Abstract] [Full Text] [Related]

  • 3. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A, Südhoff T, Meierkord F.
    Semin Thromb Hemost; 1997 Feb; 23(4):391-402. PubMed ID: 9263357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
    Cortelazzo S, Barbui T, Bassan R, Dini E.
    Thromb Haemost; 1980 Jun 18; 43(2):127-30. PubMed ID: 7455970
    [Abstract] [Full Text] [Related]

  • 7. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
    Grignani C, Noris P, Tinelli C, Barosi G, Balduini CL.
    Platelets; 2009 Mar 18; 20(2):131-4. PubMed ID: 19235056
    [Abstract] [Full Text] [Related]

  • 8. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B, Nouvel C, Sie P, Caranobe C, Combes D, Laurent G, Pris J, Bierme R.
    Scand J Haematol; 1980 Sep 18; 25(3):214-20. PubMed ID: 7466310
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
    Laharrague PF, Corberand JX, Fillola G, Boneu BP, Pris JF.
    Biomed Pharmacother; 1984 Sep 18; 38(9-10):462-5. PubMed ID: 6597727
    [Abstract] [Full Text] [Related]

  • 10. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E.
    Ann Acad Med Stetin; 1998 Sep 18; 44():137-54. PubMed ID: 9857536
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An inherited macrothrombocytopenic disorder with abnormal large granules.
    Wu S, Wang Z, Dai L, Huang R, Wang X, Li S, Bai X, Mao D, Ruan C.
    Platelets; 2006 Jun 18; 17(4):259-65. PubMed ID: 16769603
    [Abstract] [Full Text] [Related]

  • 13. [Blood platelet changes in myeloproliferative disorders].
    D'Angelo G, Calvano D, Giardini C.
    Minerva Med; 1988 Oct 18; 79(10):853-7. PubMed ID: 3141845
    [Abstract] [Full Text] [Related]

  • 14. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW, Savage B, Hanson SR, Slichter SJ, Harker LA.
    J Lab Clin Med; 1984 Jun 18; 103(6):894-904. PubMed ID: 6233383
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH.
    Semin Thromb Hemost; 2006 Sep 18; 32(6):589-604. PubMed ID: 16977569
    [Abstract] [Full Text] [Related]

  • 17. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K, Ostermann G, Hochhaus A, Höche D, Till U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Sep 18; 115(4):461-4. PubMed ID: 2465953
    [Abstract] [Full Text] [Related]

  • 18. Abnormalities of platelet aggregation in chronic myeloproliferative disorders.
    Avram S, Lupu A, Angelescu S, Olteanu N, Mut-Popescu D.
    J Cell Mol Med; 2001 Sep 18; 5(1):79-87. PubMed ID: 12067453
    [Abstract] [Full Text] [Related]

  • 19. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE, Siegel F.
    Blood Cells Mol Dis; 2006 Sep 18; 36(3):379-84. PubMed ID: 16563815
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.